| Olanzapine | ACTIVE INGREDIENT | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Olanzapine | ACTIVE MOIETY | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Methylparaben Sodium | INACTIVE INGREDIENT | CR6K9C2NHK | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Polyethylene glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Propylparaben Sodium | INACTIVE INGREDIENT | 625NNB0G9N | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Tartaric acid | INACTIVE INGREDIENT | W4888I119H | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| Triacetin | INACTIVE INGREDIENT | XHX3C3X673 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Olanzapine | ACTIVE INGREDIENT | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Olanzapine | ACTIVE INGREDIENT | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Olanzapine | ACTIVE MOIETY | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Olanzapine | ACTIVE MOIETY | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| HYPROMELLOSE | INACTIVE INGREDIENT | 3NXW29V3WO | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Lactose | INACTIVE INGREDIENT | J2B2A4N98G | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ZYPREXA (OLANZAPINE) TABLET [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| Titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |
| Titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ZYPREXA (OLANZAPINE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| Triacetin | INACTIVE INGREDIENT | XHX3C3X673 | ZYPREXA (OLANZAPINE) TABLET [DISPENSING SOLUTIONS, INC.] | 1 | |